London Healthcare Week: Rinri Therapeutics is working on a hearing loss solution that uses stems cells that are turned into the precursors of auditory neurons, cells that cannot naturally regenerate

blonca9
Nov 20, 2024
1 min read

CEO Simon Chandler describes why the company is focusing on auditory neurons and the process that Rinri uses to create them. Plus, plans to enter the clinic soon.

Recent Posts

See All

On its 10-year anniversary, Arcus Biosciences is taking its 4th molecule into pivotal studies. Co-Founder & CEO Terry Rosen talks HIF-2⍺, TIGIT, and CD73

Siren Biotechnology is using an online platform to raise up to $5 million from the public in a "community round" - it might be a new avenue of funding for biotech companies

Theravance Biopharma has a key pivotal trial readout scheduled for late '25 / early '26 in symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple system atrophy (MSA)

London Healthcare Week: Rinri Therapeutics is working on a hearing loss solution that uses stems cells that are turned into the precursors of auditory neurons, cells that cannot naturally regenerate

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight